- This event has passed.
Essentials of SBIR/STTR Commercialization
March 22 • 10:00 am - 11:00 am
Do you think your research might qualify for SBIR/STTR funding?
Find out how the government’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs can provide a source of R&D funding between the initial development of your innovative idea and proof that it has potential in the marketplace. The two programs make over $4 billion in high-risk, non-dilutive capital available to innovative small companies annually.
Join this virtual workshop from 10 – 11 a.m. (CDT), Wednesday, March 22, to review the requirements and guide you through where to start, what to include, and how to show your best self. Commercialization and transition plans can be a key differentiator in the SBIR/STTR programs. It is important to know what the agencies are looking for and how to go about developing a good plan. You’ll leave knowing:
- Agency expectations for commercialization plans in your Phase I & II projects
- Where to find cost effective market research
- What to include in your finance plan and revenue stream
- What quality “support & commitment letters” are and more!
Call (605) 275-7578 or email firstname.lastname@example.org for additional information.
View these Frequently Asked Questions (FAQs) for NSF Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Phase I Programs
About BBC Entrepreneurial Training & Consulting
2020 Tibbetts award-winner BBCetc is nationally recognized for its success in helping emerging companies win SBIR/STTR funding and use it strategically to propel growth. BBCetc’s Michigan clients have been awarded more than $307 million in funding since 2002. www.bbcetc.com / 734.930.9741 / email@example.com / @BBC_etc
About the Presenter: Amanda Barnhart
Amanda joined BBCetc as Principal Consultant in 2020 after serving as the Director of Business Development and Regulatory Affairs for a Michigan manufacturing facility producing medical isotopes for cancer therapy. In addition to her directorial responsibilities, Amanda worked as a nuclear engineer, project manager, and program manager to secure over $60 million in Department of Energy, Department of Defense, Department of Homeland Security and private investor funds. Her grant writing and negotiation skills have won over 30 Phase I, Phase II, and Phase III contracts through the SBIR/STTR program and she has managed the post-award administration process for five universities and six national laboratories. Amanda secured three licenses and 20 amendments from the Nuclear Regulatory Commission and established facility registration and Drug Master Files with the Food and Drug Administration. She has an Executive MBA in Integrative Management from Michigan State University and a Bachelor’s in Materials Science and Engineering from the University of Michigan, Ann Arbor.